Use of an antiosteolytic agent in treatment of patients with bone metastases from breast cancer.
D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D002118:Calcium / Q000097:blood; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008875:Middle Aged; D010014:Osteolysis / Q000517:prevention & control; D008926:Plicamycin / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D004317:Doxorubicin; D008926:Plicamycin; D006909:Hydroxyproline; D002118:Calcium